$20M Federal Grant Renewed for Yale Tobacco Center of Regulatory Science
The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have renewed a $20 million grant for the Yale Tobacco Center of Regulatory Science (TCORS). The Yale center is led by co-directors Suchitra Krishnan-Sarin, PhD, Albert E. Kent Professor of Psychiatry; and Stephanie O’Malley, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry.
SEICHE Center for Health and Justice Targets Disease Education Through New Initiative with World Health Organization
Identifying innovative solutions to improve the health of people impacted by incarceration is part of the mission of Yale’s SEICHE Center for Health and Justice. On Monday, September 25, the Center announced its latest initiative to assist this historically underserved population, new programs to educate correctional health care workers on providing care for both non-communicable diseases such as high blood pressure or diabetes, and infectious diseases like hepatitis C.
Investigators Launch Study Aimed at Accelerating Understanding of Bipolar Disorder
A multidisciplinary team of researchers based at Yale will launch a series of studies aimed at accelerating understanding of bipolar disorder and generating new and more effective treatments. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, and in the Child Study Center and of Radiology and Biomedical Imaging, will lead the research team.
Yale Open Data Access Project Reaches Milestone in Helping to Maximize the Use of Clinical Trial Data for Research
The Yale Open Data Access (YODA) Project, a pioneering initiative to promote open science and facilitate sharing of clinical trial research data, has reached the milestone of supporting more than 100 publications.
AI More Accurately Identifies Patients With Advanced Lung Cancer Who Respond to Immunotherapy
Researchers compared AI-powered digital scoring with traditional manual scoring of the PD-L1 immune biomarker to determine if a new immunotherapy treatment, atezolizumab, could benefit patients with advanced non-small cell lung cancer.
Blavatnik Family Foundation Gives Additional $40 Million to Yale Innovation Fund
This new donation will increase the number of research awards available to Yale scientists, support a wider range of biomedical innovations, and reach deeper into the Yale community to support new and innovative research.